Stockscreener 앱 받기
0.797
6.24%
-0.053
시간 외 거래:
.80
0.003
+0.38%
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Tenaya fundraising follows resolution of clinical hold - The Pharma Letter
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data - Investing.com India
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M FundraiseWhat's Changed - Yahoo Finance
Tenaya Therapeutics (NASDAQ:TNYA) Given New $3.00 Price Target at HC Wainwright - MarketBeat
Chardan Capital Lowers Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $8.00 - MarketBeat
Chardan Capital Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
Pharma News: Will Tenaya Therapeutics Inc stock remain a Wall Street favorite2025 Market Sentiment & Weekly Return Optimization Plans - moha.gov.vn
Tenaya Stock Drops After Announcing $60M Equity OfferingTenaya Therapeutics (NASDAQ:TNYA) - Benzinga
Tenaya Therapeutics (TNYA) Price Target Lowered by HC Wainwright & Co. | TNYA Stock News - GuruFocus
Tenaya Therapeutics slumps after $60 million share sale - TradingView — Track All Markets
Tenaya Therapeutics Prices 50 Mln Unit Offering At $60 Mln, Clinical Hold Lifted On TN-201 - Nasdaq
Tenaya Therapeutics announces positive data from Phase 1b/2 trial - Traders Union
TNYA: Chardan Capital Lowers Price Target While Maintaining Buy Rating | TNYA Stock News - GuruFocus
Tenaya Therapeutics Prices $60 Million Unit Offering - marketscreener.com
Tenaya Therapeutics prices $60 million public offering of stock and warrants - Investing.com Nigeria
Tenaya Therapeutics Announces Pricing of Public Offering - The Manila Times
Tenaya Therapeutics Announces Pricing of Public Offering | Associated Press | syndication news - Enidnews.com
Tenaya Therapeutics (TNYA) prices $60M public unit sale of 50,000,000 units - Stock Titan
Tenaya Therapeutics Says FDA Hold Removed on TN-201, Posts Positive TN-401 Interim Data, Plans Stock, Warrant Offering - marketscreener.com
Tenaya Therapeutics slides after launching stock offering - TradingView — Track All Markets
Tenaya Therapeutics plans to offer stock and warrant units By Investing.com - Investing.com Canada
Tenaya Therapeutics plans to offer stock and warrant units - Investing.com
FDA lifts clinical hold on Tenaya’s heart disease gene therapy trial - Investing.com Nigeria
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy - Investing News Network
Tenaya Therapeutics stock falls on proposed share and warrant offering - Investing.com
Tenaya Therapeutics stock falls on proposed share and warrant offering By Investing.com - Investing.com UK
Tenaya Therapeutics says early trial shows promise for gene therapy in rare heart condition - marketscreener.com
Tenaya Therapeutics (Nasdaq: TNYA) proposes unit offering of common stock and warrants - Stock Titan
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical ... - Bakersfield.com
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC - The Manila Times
Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewswire
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Path To Profitability - simplywall.st
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Earnings Beat: Will Tenaya Therapeutics Inc. stock outperform growth indexesJuly 2025 Price Swings & AI Driven Stock Movement Reports - moha.gov.vn
Will Tenaya Therapeutics Inc. stock benefit from sector rotationJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Why Tenaya Therapeutics Inc. stock is considered a top pick2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform - Seeking Alpha
Can Tenaya Therapeutics Inc. stock resist market sell offs2025 Top Gainers & High Conviction Investment Ideas - Newser
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Will Tenaya Therapeutics Inc. stock return to pre crisis levelsEarnings Overview Report & Safe Entry Point Identification - Newser
Tenaya Therapeutics (TNYA) Stock Analysis Report | Financials & Insights - Benzinga
Is Tenaya Therapeutics Inc. stock attractive for hedge fundsMarket Movers & Expert Approved Trade Ideas - BỘ NỘI VỤ
Top 3 Insider Stock Buys in March-Are They Still Good in April? - MSN
How geopolitical tensions affect Tenaya Therapeutics Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Will Tenaya Therapeutics (NASDAQ:TNYA) Spend Its Cash Wisely? - Yahoo Finance
How supply chain issues affect Tenaya Therapeutics Inc. stock - newser.com
How resilient is Tenaya Therapeutics Inc. stock in market downturnsIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
0.36%
1.05%
자본화:
|
볼륨(24시간):